The Europe Intraosseous Infusion Devices Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Intraosseous Infusion Devices Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $85.7 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).
Intraosseous access is indispensable for healthcare providers in pre-hospital and emergency department contexts. Due to its simplicity and speed, timely intervention is critical to patient outcomes. As a result, there has been a growing recognition of the importance of these devices as essential components of emergency medical care protocols and guidelines.
Additionally, the market is characterized by ongoing technological advancements, product innovations, and evolving clinical practices to improve patient outcomes and enhance healthcare delivery. Manufacturers are developing smaller, more compact, lightweight, portable devices, making them suitable for use in various clinical environments, including pre-hospital settings, emergency departments, and military operations.
As per the data from Eurostat, in 2020, there were 153,500 deaths in the EU resulting from accidents, equivalent to 3.0 % of all deaths among residents. In Slovenia, Finland, the Netherlands, France, Estonia (among the EU Member States), and Norway and Iceland (among the EFTA countries), the proportion of deaths from accidents in 2020 was at least 4.0 %. Slovenia exhibited the greatest proportion (5.4%) among the Member States of the European Union, surpassing Finland by 1.1 percentage points (4.3 percent), which held the second-highest share. Therefore, the increasing number of trauma cases in Europe will boost the region's demand for these devices.
Based on Devices Type, the market is segmented into Manual IO Needles, Battery Powered Driver and Impact Driven Devices. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Intraosseous Infusion Devices Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $85.7 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).
Intraosseous access is indispensable for healthcare providers in pre-hospital and emergency department contexts. Due to its simplicity and speed, timely intervention is critical to patient outcomes. As a result, there has been a growing recognition of the importance of these devices as essential components of emergency medical care protocols and guidelines.
Additionally, the market is characterized by ongoing technological advancements, product innovations, and evolving clinical practices to improve patient outcomes and enhance healthcare delivery. Manufacturers are developing smaller, more compact, lightweight, portable devices, making them suitable for use in various clinical environments, including pre-hospital settings, emergency departments, and military operations.
As per the data from Eurostat, in 2020, there were 153,500 deaths in the EU resulting from accidents, equivalent to 3.0 % of all deaths among residents. In Slovenia, Finland, the Netherlands, France, Estonia (among the EU Member States), and Norway and Iceland (among the EFTA countries), the proportion of deaths from accidents in 2020 was at least 4.0 %. Slovenia exhibited the greatest proportion (5.4%) among the Member States of the European Union, surpassing Finland by 1.1 percentage points (4.3 percent), which held the second-highest share. Therefore, the increasing number of trauma cases in Europe will boost the region's demand for these devices.
Based on Devices Type, the market is segmented into Manual IO Needles, Battery Powered Driver and Impact Driven Devices. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Aero Healthcare AU Pty Ltd
- Teleflex Incorporated
- Becton, Dickinson and Company
- BIOPSYBELL S.R.L.
- Cook Medical, Inc.(Cook Group)
- The Seaberg Company Inc. (SAM Medical)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Medax Srl
- PAVmed Inc.
Market Report Segmentation
By Devices Type- Manual IO Needles
- Battery Powered Driver
- Impact Driven Devices
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Intraosseous Infusion Devices Market by Devices Type
Chapter 5. Europe Intraosseous Infusion Devices Market by End User
Chapter 6. Europe Intraosseous Infusion Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Aero Healthcare AU Pty Ltd
- Teleflex Incorporated
- Becton, Dickinson and Company
- BIOPSYBELL S.R.L.
- Cook Medical, Inc.(Cook Group)
- The Seaberg Company Inc. (SAM Medical)
- Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
- Medax Srl
- PAVmed Inc.
Methodology
LOADING...
